Joseph J Eron

Joseph J Eron

UNVERIFIED PROFILE

Are you Joseph J Eron?   Register this Author

Register author
Joseph J Eron

Joseph J Eron

Publications by authors named "Joseph J Eron"

Are you Joseph J Eron?   Register this Author

98Publications

2238Reads

6Profile Views

Estimating Human Immunodeficiency Virus (HIV) Prevention Effects in Low-incidence Settings.

Epidemiology 2019 05;30(3):358-364

From the Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0000000000000966DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456405PMC
May 2019

Evolution of HIV-1 drug resistance after virological failure of first-line antiretroviral therapy in Lusaka Zambia.

Antivir Ther 2019 Apr 12. Epub 2019 Apr 12.

UNC Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3851/IMP3299DOI Listing
April 2019

HIV-1 Phylodynamics to Detect and Characterize Active Transmission Clusters in North Carolina.

J Infect Dis 2019 Apr 27. Epub 2019 Apr 27.

Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/jid/advance-article/doi/10.1093/inf
Publisher Site
http://dx.doi.org/10.1093/infdis/jiz176DOI Listing
April 2019

Prediction of HIV Transmission Cluster Growth With Statewide Surveillance Data.

J Acquir Immune Defic Syndr 2019 Feb;80(2):152-159

Institute for Global Health and Infectious Diseases, The University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001905DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692892PMC
February 2019

Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation.

J Acquir Immune Defic Syndr 2018 Dec;79(4):510-518

Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001843DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203616PMC
December 2018

HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected Individuals.

Mol Ther 2018 10 21;26(10):2496-2506. Epub 2018 Sep 21.

UNC HIV Cure Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2018.08.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171327PMC
October 2018

Sensitivity Analyses for Misclassification of Cause of Death in the Parametric G-Formula.

Am J Epidemiol 2018 08;187(8):1808-1816

School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/aje/kwy028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070049PMC
August 2018

Leveraging Phylogenetics to Understand HIV Transmission and Partner Notification Networks.

J Acquir Immune Defic Syndr 2018 Aug;78(4):367-375

Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001695DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058319PMC
August 2018

Prevalence and Transmission Dynamics of HIV-1 Transmitted Drug Resistance in a Southeastern Cohort.

Open Forum Infect Dis 2018 Aug 20;5(8):ofy178. Epub 2018 Jul 20.

Division of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofy178DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101542PMC
August 2018

T cells establish and maintain CNS viral infection in HIV-infected humanized mice.

J Clin Invest 2018 Jul 4;128(7):2862-2876. Epub 2018 Jun 4.

Division of Infectious Diseases, Center for AIDS Research (CFAR), University of North Carolina at Chapel Hill (UNC-CH), School of Medicine, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI98968DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026008PMC
July 2018

Effects of Health Insurance Interruption on Loss of Hypertension Control in Women With and Women Without HIV.

J Womens Health (Larchmt) 2017 12 6;26(12):1292-1301. Epub 2017 Jul 6.

1 Department of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill , Chapel Hill, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jwh.2016.6308DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733655PMC
December 2017

Increased Persistence of Initial Treatment for HIV Infection With Modern Antiretroviral Therapy.

J Acquir Immune Defic Syndr 2017 10;76(2):111-115

Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001481DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597479PMC
October 2017

HIV Care Initiation Delay Among Rural Residents in the Southeastern United States, 1996 to 2012.

J Acquir Immune Defic Syndr 2017 10;76(2):171-176

*Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC; †Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC; ‡Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL; and §Department of Epidemiology, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001483DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850947PMC
October 2017

Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016.

AIDS 2017 10;31(16):2235-2244

aDivision of Global Health and Infectious Diseases bDepartment of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina, Chapel Hill cDivision of HIV/AIDS, North Carolina Department of Public Health, Raleigh, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001611DOI Listing
October 2017

Incomplete viral suppression and mortality in HIV patients after antiretroviral therapy initiation.

AIDS 2017 09;31(14):1989-1997

aDepartment of Epidemiology bCenter for AIDS Research cDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina dDivision of Epidemiology, Ohio State University, Columbus, Ohio eJohns Hopkins University, Baltimore, Maryland fUniversity of Washington, Seattle, Washington gUniversity of California, San Diego, California hHarvard University, Cambridge, Massachusetts iUniversity of California, San Francisco, California jDivision of Infectious Diseases, Department of Medicine, Center for Global Health, Feinberg School of Medicine, Northwestern University, Chicago, Illinois kDepartment of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001573DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5695564PMC
September 2017

Risk factors for delayed antiretroviral therapy initiation among HIV-seropositive patients.

PLoS One 2017 10;12(7):e0180843. Epub 2017 Jul 10.

Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0180843PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507276PMC
September 2017

Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016.

AIDS 2017 10;31(16):2235-2244

aDivision of Global Health and Infectious Diseases bDepartment of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina, Chapel Hill cDivision of HIV/AIDS, North Carolina Department of Public Health, Raleigh, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001611DOI Listing
October 2017

Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared With the General Population.

J Acquir Immune Defic Syndr 2017 08;75(5):568-576

*Department of Medicine, University of Washington School of Medicine, Seattle, WA; †Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; ‡Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC; §Department of Medicine, University of Alabama School of Medicine, Birmingham, AL; ‖Department of Medicine, University of California San Diego, San Diego, CA; ¶Kaiser Permanente Division of Research, Oakland, CA; #Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN; **Department of Epidemiology, University of Washington School of Public Health, Seattle, WA; ††Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; ‡‡Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; §§Department of Medicine, George Washington University School of Medicine, Washington, DC; ‖‖Department of Clinical Investigations, Whitman Walker Health, Washington, DC; ¶¶Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA; ##Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA; ***Department of Medicine, Yale School of Public Health, New Haven, CT; †††Department of Infectious Diseases, San Leandro Medical Center, San Leandro, CA; and ‡‡‡Department of Medicine, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001450DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522001PMC
August 2017

US Black Women and Human Immunodeficiency Virus Prevention: Time for New Approaches to Clinical Trials.

Clin Infect Dis 2017 Jul;65(2):324-327

Department of Medicine, University of North Carolina School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cix313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850546PMC
July 2017

Brief Report: Longitudinal Opioid Use Among HIV-Infected Patients, 2000 to 2014.

J Acquir Immune Defic Syndr 2017 05;75(1):77-80

*Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; and †Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000001321DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388582PMC
May 2017

Rising prevalence of non-B HIV-1 subtypes in North Carolina and evidence for local onward transmission.

Virus Evol 2017 Jan 24;3(1):vex013. Epub 2017 May 24.

Division of Infectious Diseases, University of North Carolina, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ve/vex013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442504PMC
January 2017

Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.

AIDS 2016 11;30(18):2815-2822

aDepartment of Medicine, UNC Institute for Global Health & Infectious Diseases bDepartment of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill cDepartment of Medicine, Division of Infectious Diseases dDepartment of Surgery eDuke Human Vaccine Institute, Duke University, Durham fLaboratory Corporation of America, Burlington, North Carolina gDepartment of Clinical Medicine, University of San Diego, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101138PMC
November 2016

Impact of Health Insurance, ADAP, and Income on HIV Viral Suppression Among US Women in the Women's Interagency HIV Study, 2006-2009.

J Acquir Immune Defic Syndr 2016 11;73(3):307-312

*Division of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, NC;Departments of †Epidemiology;‡Health Policy and Management, UNC Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC;§Departments of Medicine and Epidemiology and Population Health, Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY;‖Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, CA;¶Department of Medicine, Cook County Health and Hospital System, Rush University, Chicago, IL;**Department of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, Atlanta, GA;††Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD;‡‡Division of Infectious Diseases and Travel Medicine, Department of Medicine, Georgetown University, Washington, DC;§§Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS;‖‖Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, New York, NY;¶¶Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA; and***Department of Community Health Sciences, School of Public Health, State University of New York (SUNY) Downstate Medical Center, Brooklyn, NY.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089078PMC
http://dx.doi.org/10.1097/QAI.0000000000001078DOI Listing
November 2016

Neurocognition with maraviroc compared with tenofovir in HIV.

AIDS 2016 09;30(15):2315-21

aUniversity of North Carolina at Chapel Hill, Chapel Hill, North Carolina bHarvard University, Boston, Massachusetts cJohns Hopkins Hospital, Baltimore, Maryland dNorthwestern University, Chicago, Illinois eFrontier Science & Technology, Amherst, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001189DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014739PMC
September 2016

Changes in Clinical Context for Kaposi's Sarcoma and Non-Hodgkin Lymphoma Among People With HIV Infection in the United States.

J Clin Oncol 2016 09 9;34(27):3276-83. Epub 2016 Aug 9.

Elizabeth L. Yanik, Anna E. Coghill, and Eric A. Engels, National Cancer Institute, Rockville; Richard D. Moore, Johns Hopkins University, Baltimore, MD; Chad J. Achenbach, Northwestern University, Chicago, IL; Satish Gopal, Stephen R. Cole, and Joseph J. Eron, University of North Carolina at Chapel Hill, Chapel Hill, NC; W. Christopher Mathews, University of California, San Diego, San Diego, CA; Daniel R. Drozd, University of Washington, Seattle, WA; Ayad Hamdan, Beth Israel Deaconess Medical Center, Boston, MA; and Mary E. Ballestas, University of Alabama at Birmingham, Birmingham, AL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.67.6999DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024548PMC
September 2016

Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.

J Acquir Immune Defic Syndr 2016 08;72(4):437-43

Departments of *Medicine; †Epidemiology, University of Washington, Seattle, WA; ‡Department of Medicine, University of California-San Diego, San Diego, CA; §Department of Medicine, University of California-San Francisco, San Francisco, CA; ‖Department of Medicine, Harvard University, Fenway Health, Boston, MA; ¶Department of Medicine, Case Western University, Cleveland, OH; #Department of Medicine, University of North Carolina, Chapel Hill, NC; **Department of Medicine, University of Alabama, Birmingham, AL; and ††Department of Medicine, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000992DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925189PMC
August 2016

Differential CD4+ cell count increase and CD4+ :  CD8+ ratio normalization with maraviroc compared with tenofovir.

AIDS 2016 08;30(13):2091-7

aStatistical and Data Analysis Center, Harvard Chan School of Public Health, Boston, Massachusetts bDepartment of Immunology and Microbiology, Rush University Medical Center, Chicago, Illinois cDivision of Endocrinology, Diabetes, and Metabolism, Johns Hopkins University, Baltimore, Maryland dDivision of Infectious Diseases eDivision of Endocrinology and Metabolism and Lipids, Emory University, Atlanta; Atlanta VA Medical Center, Decatur, Georgia fHIV Research Branch, Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland gDivision of Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina hDivision of Infectious Diseases, University of Cincinnati, Cincinnati, Ohio iDivision of Infectious Diseases, Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4966543PMC
August 2016

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial.

J Acquir Immune Defic Syndr 2016 07;72(3):304-9

1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD; 2Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA; 3Frontier Science & Technology Research Foundation, Amherst, NY; 4Specialty Molecular Division, Lancet Laboratories and BARC-SA, Johannesburg, South Africa; 5Laboratory of AIDS and Molecular Immunology, Oswaldo Cruz Institute, Rio de Janeiro, Brazil; 6Y. R. Gaitonde Centre for AIDS Research and Education, Chennai, India; 7National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, India; 8Science Facilitation Department, FHI 360, Washington, DC; 9Science Facilitation Department, FHI 360, Durham, NC; 10Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; 11Southwest CARE Center, Santa Fe, NM; 12College of Medicine-Johns Hopkins Project, Blantyre, Malawi; 13Botswana Harvard AIDS Institute, Gaborone, Botswana; 14YRGCARE Medical Centre, VHS, Chennai, India; 15Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand; 16Department of Medicine, University of Zimbabwe, Harare, Zimbabwe; 17Wits Reproductive Health and HIV Institute, University of Witwatersrand, Johannesburg, South Africa; 18Kenya Medical Research Institute, Center for Disease Control, Kisumu, Kenya; 19Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC; 20UNC Project-Malawi, Institute for Global Health and Infectious Diseases, Lilongwe, Malawi; 21Serviço de Infectologia, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil; 22Department of Epidemiology and Biostatistics, National AIDS Research Institute (ICMR), Pune, India; 23Hospital Geral de Nova Iguacu and Laboratorio de AIDS e Imunologia Molecular-IOC/Fiocruz, Rio de Janeiro, Brazil; 24Instituto Nacional de Infectologia Evandro Chagas-INI-Fiocruz, Rio de Janeiro, Brazil; 25Perinatal HIV Research Unit, University of the Witwatersrand, Soweto HPTN CRS, S

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000951DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911290PMC
July 2016

Hypertension Among HIV-infected Patients in Clinical Care, 1996-2013.

Clin Infect Dis 2016 07 18;63(2):242-8. Epub 2016 Apr 18.

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciw223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276923PMC
July 2016

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.

J Virol 2016 07 10;90(13):6058-6070. Epub 2016 Jun 10.

Department of Medicine, Stanford University, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.00495-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907232PMC
July 2016

When to Monitor CD4 Cell Count and HIV RNA to Reduce Mortality and AIDS-Defining Illness in Virologically Suppressed HIV-Positive Persons on Antiretroviral Therapy in High-Income Countries: A Prospective Observational Study.

J Acquir Immune Defic Syndr 2016 Jun;72(2):214-21

1Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA; 2University College London, London, United Kingdom; 3Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA; 4Sorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France; 5Assistance Publique-Hopitaux de Paris (AP-HP), Hopital Antoine Béclère, Service de Médecine Interne, Clamart, France; 6University of Alabama at Birmingham, Birmingham, AL; 7Université Paris Sud, INSERM CESP U1018, and AP-HP, Hopital de Bicêtre, Service de Santé Publique, le Kremlin Bicêtre, France; 8Division of Allergy and Infectious Diseases, School of Medicine, University of Washington, Seattle, WA; 9Bordeaux University, ISPED, INSERM U897 CHU de Bordeaux, Bordeaux, France; 10INSERM U897, Centre Inserm Epidémiologie et Biostatistique, Université de Bordeaux, and Department of Internal Medicine, Bordeaux University Hospital, Bordeaux, France; 11School of Medicine, Johns Hopkins University, Baltimore, MD; 12Stichting HIV Monitoring, Amsterdam, Netherlands; Academic Medical Center, Department of Global Health and Division of Infectious Diseases, University of Amsterdam, and Amsterdam Institute for Global Health and Development, Amsterdam, Netherlands; 13Stichting HIV Monitoring, Amsterdam, Netherlands; 14Internal Medicine, Johns Hopkins University, Baltimore, MD; 15National Centre of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain; Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; 16Ramón y Cajal Hospital, IRYCIS, Madrid, Spain, University of Alcalá de Henares, Madrid, Spain; 17Positive Health Program, San Francisco General Hospital, San Francisco, CA; 18Servei de Medicina Interna, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain; 19Fenway Health, Boston, MA; 20Hospital Universitari d

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000000956DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4866894PMC
June 2016

HIV primary care providers--Screening, knowledge, attitudes and behaviors related to alcohol interventions.

Drug Alcohol Depend 2016 Apr 29;161:59-66. Epub 2016 Jan 29.

Department of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine, 550 N. Broadway, Baltimore, MD 21205, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2016.01.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4841449PMC
April 2016

The effect of antiretroviral therapy on all-cause mortality, generalized to persons diagnosed with HIV in the USA, 2009-11.

Int J Epidemiol 2016 Feb 15;45(1):140-50. Epub 2016 Jan 15.

Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ije/dyv352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013889PMC
February 2016